These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9593010)

  • 1. Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus.
    Doyle WJ; Skoner DP; Alper CM; Allen G; Moody SA; Seroky JT; Hayden FG
    J Infect Dis; 1998 May; 177(5):1260-5. PubMed ID: 9593010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus.
    Skoner DP; Gentile DA; Patel A; Doyle WJ
    J Infect Dis; 1999 Jul; 180(1):10-4. PubMed ID: 10353855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of naturally occurring influenza A/USSR/77 H1N1.
    Van Voris LP; Betts RF; Hayden FG; Christmas WA; Douglas RG
    JAMA; 1981 Mar; 245(11):1128-31. PubMed ID: 7007668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine.
    Hayden FG; Sperber SJ; Belshe RB; Clover RD; Hay AJ; Pyke S
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1741-7. PubMed ID: 1952841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults.
    Hayden FG; Monto AS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):339-41. PubMed ID: 3521480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children.
    Thompson J; Fleet W; Lawrence E; Pierce E; Morris L; Wright P
    J Med Virol; 1987 Mar; 21(3):249-55. PubMed ID: 3549971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.
    Englund JA; Champlin RE; Wyde PR; Kantarjian H; Atmar RL; Tarrand J; Yousuf H; Regnery H; Klimov AI; Cox NJ; Whimbey E
    Clin Infect Dis; 1998 Jun; 26(6):1418-24. PubMed ID: 9636873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
    Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
    Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rimantadine: a clinical perspective.
    Wintermeyer SM; Nahata MC
    Ann Pharmacother; 1995 Mar; 29(3):299-310. PubMed ID: 7606077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.
    Hayden FG; Belshe RB; Clover RD; Hay AJ; Oakes MG; Soo W
    N Engl J Med; 1989 Dec; 321(25):1696-702. PubMed ID: 2687687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of rimantadine prophylaxis of children within families.
    Clover RD; Crawford SA; Abell TD; Ramsey CN; Glezen WP; Couch RB
    Am J Dis Child; 1986 Jul; 140(7):706-9. PubMed ID: 3521258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
    Dolin R; Reichman RC; Madore HP; Maynard R; Linton PN; Webber-Jones J
    N Engl J Med; 1982 Sep; 307(10):580-4. PubMed ID: 7050702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal and otologic effects of experimental influenza A virus infection.
    Doyle WJ; Skoner DP; Hayden F; Buchman CA; Seroky JT; Fireman P
    Ann Otol Rhinol Laryngol; 1994 Jan; 103(1):59-69. PubMed ID: 8291861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.
    Ison MG; Gnann JW; Nagy-Agren S; Treannor J; Paya C; Steigbigel R; Elliott M; Weiss HL; Hayden FG;
    Antivir Ther; 2003 Jun; 8(3):183-90. PubMed ID: 12924534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged influenza A infection responsive to rimantadine therapy in a human immunodeficiency virus-infected child.
    Evans KD; Kline MW
    Pediatr Infect Dis J; 1995 Apr; 14(4):332-4. PubMed ID: 7603824
    [No Abstract]   [Full Text] [Related]  

  • 17. Children with influenza A infection: treatment with rimantadine.
    Hall CB; Dolin R; Gala CL; Markovitz DM; Zhang YQ; Madore PH; Disney FA; Talpey WB; Green JL; Francis AB
    Pediatrics; 1987 Aug; 80(2):275-82. PubMed ID: 3302925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.
    Marra F; Marra CA; Stiver HG
    Can Respir J; 2003 Oct; 10(7):381-8. PubMed ID: 14571290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic.
    Brady MT; Sears SD; Pacini DL; Samorodin R; DePamphilis J; Oakes M; Soo W; Clements ML
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1633-6. PubMed ID: 2285274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal and otologic effects of experimental respiratory syncytial virus infection in adults.
    Buchman CA; Doyle WJ; Pilcher O; Gentile DA; Skoner DP
    Am J Otolaryngol; 2002; 23(2):70-5. PubMed ID: 11893972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.